Sign In

Richard Sear

Business Unit Director - Value, Price & Access at Dolon Ltd

Richard Sear is a Director at Dolon Ltd, a consultancy specializing in market access and strategic pricing for rare disease treatments. He has over 10 years of experience in pricing, reimbursement, and market access consultancy. Prior to joining Dolon, he worked at McKinsey & Company as part of the EU Value and Access service line, where he focused on developing evidence-based strategies for pricing and reimbursement in health systems.12

Sear's expertise lies in helping clients navigate complex market access challenges, leveraging his background in health systems and problem-solving skills to create effective pricing strategies for pharmaceutical products. He is based in London and has a strong educational background, having studied at The London School of Economics and Political Science (LSE).3

Highlights

Nov 6 · linkedin

Do proposed changes to EU pharma legislation risk damaging the biotech ecosystem in Europe?

A report published today by Dolon Ltd , commissioned by EFPIA, looked at the potential impact of proposed reforms on innovation, competitiveness of the region and patient access to medicines. Topline findings in the linked article. Full report available on the Dolon website

Aug 4 · linkedin

Dolon is hiring. We specialise in market access strategy and policy for rare disease medicines. If you are interested to learn more, please get in touch. #hiring #strategy #rarediseases

Related Questions

What are Richard Sear's main responsibilities at Dolon Ltd?
How did Richard Sear's role at McKinsey & Co prepare him for his position at Dolon Ltd?
What specific projects has Richard Sear led at Dolon Ltd?
How does Richard Sear's background in health systems benefit Dolon's clients?
What are some notable achievements of Richard Sear in the field of market access consultancy?
Richard Sear
Richard Sear, photo 1
Richard Sear, photo 2
Add to my network

Location

London, England, United Kingdom